Epstein–Barr virus hijacks B cell metabolism to establish persistent infection and drive pathogenesis
Open Access
- 20 December 2024
- journal article
- review article
- Published by Elsevier in Trends in Immunology
- Vol. 46 (1) , 7-16
Abstract
No abstract availableKeywords
Funding Information
- Swiss Cancer League
- Swiss National Science Foundation (PZ00P3_216467/1)
- Universität Basel (EP 21161105.8)
This publication has 65 references indexed in Scilit:
- Epstein-Barr virus latency patterns in polymorphic lymphoproliferative disorders and lymphomas in immunodeficiency settings: Diagnostic implicationsAnnals of Diagnostic Pathology, 2024
- Epstein-Barr virus: Biology and clinical diseaseCell, 2022
- Methionine metabolism controls the B cell EBV epigenome and viral latencyCell Metabolism, 2022
- Methionine restriction forces Epstein-Barr virus out of latencyCell Metabolism, 2022
- Evidence of Epstein‐Barr virus heterogeneous gene expression in adult lung transplant recipients with posttransplant lymphoproliferative disorderJournal of Medical Virology, 2021
- Epstein-Barr-Virus-Induced One-Carbon Metabolism Drives B Cell TransformationCell Metabolism, 2019
- Metabolic Instruction of ImmunityCell, 2017
- One-Carbon Metabolism in Health and DiseaseCell Metabolism, 2017
- Epstein-Barr Virus Oncoprotein Super-enhancers Control B Cell GrowthCell Host & Microbe, 2015
- LMP2A Survival and Developmental Signals Are Transmitted through Btk-Dependent and Btk-Independent PathwaysVirology, 2001